Macugen Access Program Will Help Seniors With Medicare Copay
This article was originally published in The Pink Sheet Daily
Executive Summary
MAP is designed to assure access to the ophthalmic agent for seniors who "may have difficulty paying the 20% copay," Eyetech COO says. Macugen carries an average wholesale price of $1,243 per injection.
You may also be interested in...
McKesson, Priority And Besse Will Distribute Pfizer/Eyetech's Macugen
McKesson, Priority and Besse will be specialty distributors for Pfizer/Eyetech's wet age-related macular degeneration treatment Macugen (pegaptanib)
McKesson, Priority And Besse Will Distribute Pfizer/Eyetech's Macugen
McKesson, Priority and Besse will be specialty distributors for Pfizer/Eyetech's wet age-related macular degeneration treatment Macugen (pegaptanib)
Pfizer/Eyetech Macugen To Launch In First Quarter With "Unambiguous" Label
The ophthalmic agent clears FDA under priority review procedures; "It is for all neovascular" age-related macular degeneration, Eyetech COO says. Company expects Macugen will receive broad coverage under Medicare Part B.